 Subjects must be taking optimized levodopacarbidopa or levodopa benserazide carbidopalevodopa therapy based on investigators judgment, stable for at least 14 days prior to baseline. Subjects must be receiving at least 3 daily doses of levodopa, not including a bedtime dose. 